1,1,2-triphenylbut-1-ene derivatives for treating...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/135 (2006.01) A61K 31/138 (2006.01)

Patent

CA 2198561

The present invention provides a pharmaceutical composition for inhibiting Alzheimer's Disease in a human in need of treatment, which composition comprises an effective amount of a compound of formula I (see fig. I) (I) wherein R1 and R~ may be the same or different provided that, when R1 and R~ are the same, each is a methyl or ethyl group, and, when R1 and R~ are different, one of them is a methyl or ethyl group and the other is hydrogen or a benzyl group; or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable diluent or carrier.

Composition pharmaceutique pour l'inhibition de la maladie d'Alzheimer chez une personne nécessitant un traitement. La composition renferme une quantité efficace : d'un composé de formule I (voir fig. I), où R1 et R2 peuvent être les mêmes ou différents, à condition que, si R1 et R2 sont les mêmes, chacun est un méthyle ou un éthyle, et si R1 et R2 sont différents, l'un est un méthyle ou un éthyle et l'autre de l'hydrogène ou un benzyle; ou d'un sel correspondant, acceptable en pharmacie, avec un diluant ou un véhicule, acceptable lui aussi en pharmacie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

1,1,2-triphenylbut-1-ene derivatives for treating... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,1,2-triphenylbut-1-ene derivatives for treating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,1,2-triphenylbut-1-ene derivatives for treating... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2061077

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.